A Study to Learn About the Outcomes Between Study Medicines, Enzalutamide and Darolutamide Among Men With Metastatic Castration Sensitive Prostate Cancer (mCSPC)

NCT07779590 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
4700
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer